Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Ultraschall Med ; 11(1): 48-50, 1990 Feb.
Artigo em Alemão | MEDLINE | ID: mdl-2138815

RESUMO

Case report on a severe cardial malformation associated with trisomia 21, diagnosed by ultrasound-screening in the 34th week of gestation. Further diagnostic evaluation of the case and therapeutic management are described. The problems of modern malformation diagnostics by routine ultrasound scanning in pregnancy are discussed.


Assuntos
Síndrome de Down/diagnóstico , Cardiopatias Congênitas/diagnóstico , Diagnóstico Pré-Natal , Ultrassonografia , Adulto , Ecocardiografia , Feminino , Humanos , Recém-Nascido , Masculino , Gravidez , Terceiro Trimestre da Gravidez
2.
Chemotherapy ; 36(4): 245-50, 1990.
Artigo em Inglês | MEDLINE | ID: mdl-2253494

RESUMO

The ability of an antibiotic to penetrate into the extravascular site of infection is particularly important for a successful perioperative antibiotic prophylaxis and postoperative therapy of bacterial infection. We, therefore, measured interstitial fluid concentrations of ceftriaxone in the subperitoneal space following hysterectomy using Rubinstein's disc method after intravenous administration of 1 g of ceftriaxone preoperatively. After removal of the uterus, two disc units were implanted intraoperatively in the right and left subperitoneal space of 16 patients and were drawn out through the open vaginal cuff after given periods of time. Five disc and blood specimens were obtained after 90 min and 2, 6, 12, 24, and 48 h, respectively. Ceftriaxone concentrations were determined by bioassay. After administration of 1 g of ceftriaxone, interstitial fluid concentrations following hysterectomy were above the MIC90 of most pathogens encountered in gynecologic infections over a period of 24 h.


Assuntos
Ceftriaxona/análise , Espaço Extracelular/análise , Histerectomia Vaginal , Técnicas Bacteriológicas , Ceftriaxona/administração & dosagem , Ceftriaxona/sangue , Feminino , Humanos , Cavidade Peritoneal , Próteses e Implantes , Fatores de Tempo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...